Evidence map›Paper›PMID 34945351›Full record

ArticleMicromachines2021

A 3D Microfluidic ELISA for the Detection of Severe Dengue: Sensitivity Improvement and Vroman Effect Amelioration by EDC-NHS Surface Modification.

Hinata Maeno, Pooi-Fong Wong, Sazaly AbuBakar, Ming Yang, Sing-Sin Sam, Juraina Jamil-Abd, Anusha Shunmugarajoo, Mahiran Mustafa, Rosaida Md Said, Eashwary Mageswaren and 2 more

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Hinata MaenoDepartment of System Design, Tokyo Metropolitan University, Tokyo 191-0065, Japan.
Pooi-Fong WongDepartment of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0002-6705-2521
Sazaly AbuBakarTropical Infectious Diseases Research and Educational Centre (TIDREC), University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0002-9267-1420
Ming YangDepartment of System Design, Tokyo Metropolitan University, Tokyo 191-0065, Japan.
Sing-Sin SamTropical Infectious Diseases Research and Educational Centre (TIDREC), University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0003-2527-5310
Juraina Jamil-AbdTropical Infectious Diseases Research and Educational Centre (TIDREC), University of Malaya, Kuala Lumpur 50603, Malaysia.
Anusha ShunmugarajooMedical Department, Tengku Ampuan Rahimah Hospital, Klang 41200, Malaysia.
Mahiran MustafaMedical Department, Raja Perempuan Zainab II Hospital, Kota Bharu 15200, Malaysia.
Rosaida Md SaidMedical Department, Ampang Hospital, Ampang 68000, Malaysia.
Eashwary MageswarenMedical Department, Tengku Ampuan Rahimah Hospital, Klang 41200, Malaysia.ORCID 0000-0002-4747-8541
Azureen AzmelMedical Department, Tengku Ampuan Rahimah Hospital, Klang 41200, Malaysia.
Anilawati Mat JelaniMedical Department, Raja Perempuan Zainab II Hospital, Kota Bharu 15200, Malaysia.
Tengku Ampuan Rahimah Hospital · MYUniversity Malaya Medical Centre · MYHospital Raja Perempuan Zainab II · MYTokyo Metropolitan University · JPKPJ Ampang Puteri Specialist Hospital · MYUniversity of Malaya · MY

Funding

Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malay-sia FP0514B0025-2 (DSTIN) WorkPackage 5C (GA019-2016)
6 · The paper itself

Abstract

Serum is commonly used as a specimen in immunoassays but the presence of heterophilic antibodies can potentially interfere with the test results. Previously, we have developed a microfluidic device called: 3D Stack for enzyme-linked immunosorbent assay (ELISA). However, its evaluation was limited to detection from a single protein solution. Here, we investigated the sensitivity of the 3D Stack in detecting a severe dengue biomarker-soluble CD163 (sCD163)-within the serum matrix. To determine potential interactions with serum matrix, a spike-and-recovery assay was performed, using 3D Stacks with and without surface modification by an EDC-NHS (N-ethyl-N'-(3-(dimethylamino)propyl)carbodiimide/N-hydroxysuccinimide) coupling. Without surface modification, a reduced analyte recovery in proportion to serum concentration was observed because of the Vroman effect, which resulted in competitive displacement of coated capture antibodies by serum proteins with stronger binding affinities. However, EDC-NHS coupling prevented antibody desorption and improved the sensitivity. Subsequent comparison of sCD163 detection using a 3D Stack with EDC-NHS coupling and conventional ELISA in dengue patients' sera revealed a high correlation (R = 0.9298,

Indexed as

EDC–NHS couplingELISAmicrofluidics

Identifiers

PMID34945351
PMCPMC8715748
OpenAlexW3217443476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.